🔎 Trials Near Me

Dachaigh › Ailse a' Chinn agus a' Mhuineil › Tennessee › Nashville

Sgrùdaidhean clionaigeach Ailse a' Chinn agus a' Mhuineil ann an Nashville, TN

Tha 21 sgrùdaidhean airson Ailse a' Chinn agus a' Mhuineil a’ lorg phàirtichean aig làraichean ann agus timcheall air Nashville (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

A’ fastadhÌre 1/2
  • Sarah Cannon Research Institute, Nashville
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT04585750

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

A’ fastadhÌre 2/3
  • Site#0126, Nashville
  • Site #0116, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06788990

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

A’ fastadhÌre 2
  • SCRI Oncology Partners, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06172478

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

A’ fastadhÌre 1
  • Sarah Cannon Research Institute - Pharmacy, Nashville
  • SCRI Oncology Partners, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07090499

DESTINY-PANTUMOUR04

A’ fastadhSgrùdadh amharc
  • Research Site, Nashville
Aoisean 18 gu 130 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07124000

A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

A’ fastadhÌre 1
  • Sarah Cannon and HCA Research Institute, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Sult 2026 · NCT07462377

Self-Management for Head and Neck Lymphedema and Fibrosis [PROMISE Trial]

A’ fastadh
  • Barbara Murphy, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT06125743

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

A’ fastadhÌre 1/2
  • Sarah Cannon Research Institute Oncology Partners (SCRI-Nashville), Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Lùna 2026 · NCT05592626

Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer

A’ fastadhÌre 1
  • Vanderbilt University Medical Center, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Lùna 2026 · NCT06819228

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

A’ fastadhÌre 1/2
  • Sarah Cannon Research Institute, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Iuch 2026 · NCT05768139

Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)

A’ fastadhÌre 1
  • Vanderbilt University Medical Center, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Iuch 2026 · NCT07460765

Photobiomodulation in Head and Neck Cancer-Related Chronic Lymphedema

A’ fastadh
  • Vanderbilt University Medical Center, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Ògmh 2026 · NCT06837480

A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

A’ fastadhÌre 3
  • GSK Investigational Site, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 26 Cèit 2026 · NCT06256588

High-Resolution PET-CT Imaging for Surgical Margin Visualization

A’ fastadh
  • Vanderbilt University Medical Center, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Cèit 2026 · NCT06915454

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

A’ fastadhÌre 1/2
  • Sarah Cannon Research Institute, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Cèit 2026 · NCT06239194

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
  • Vanderbilt-Ingram Cancer Center, Nashville
Aoisean 40 agus nas sine · Gach gnè · Air ùrachadh 20 Faoi 2026 · NCT05366881

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

A’ fastadhSgrùdadh amharc
  • Massive Bio SYNERGY-AI site, Nashville
Gach aois · Gach gnè · Air ùrachadh 28 Dàmh 2025 · NCT03452774

Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
  • Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville
  • Vanderbilt-Ingram Cancer Center at Franklin, Nashville
  • Veterans Affairs Medical Center - Nashville, Nashville
  • agus 1 a bharrachd
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Dàmh 2025 · NCT00898638

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

A’ fastadhÌre 1/2
  • Tennessee Oncology, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2025 · NCT05941507

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

A’ fastadhÌre 1
  • Vanderbilt University Medical Center, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Lùna 2025 · NCT04429542

Gabapentin & Ketamine for Prevention/Treatment of Acute/Chronic Pain in Locally Advanced Head and Neck Cancer

A’ fastadhÌre 1/2
  • Vanderbilt-Ingram Cancer Center, Nashville
Aoisean 21 agus nas sine · Gach gnè · Air ùrachadh 21 Dàmh 2024 · NCT05156060

Sgrùdaidhean Ailse a' Chinn agus a' Mhuineil ann am bailtean eile

Sgrùdaidhean eile ann an Nashville

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.